Moreover, the results of this study documented that the ATRA/ATO combination was of relevant benefit also in FLT3-ITD mutated cases with the abrogation of the role of this negative prognostic factor linked to higher WBC counts, and present in up to 40% of both adult and pediatric APL cases [65]. The gene discussed is FLT3; the disease is acute promyelocytic leukemia.